Healthconn Corp (6665) Fair Value & Analysis
Healthcare · TW · Market cap 882M TWD
Fair value as of: Jul 23, 2026
From 26 valuation models · updated 18 days ago
Share price −11.0% over the past month.
A solid business, but screening 74% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (6.62 TWD). The favourable scenario is already priced in.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (3.05 TWD to 6.62 TWD) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 23, 2026.
How to read this chart
60‑month range 17.35 TWD – 60.68 TWD · fair‑value band 3.05 TWD – 6.62 TWD · the 18.70 TWD price screens above the 4.88 TWD fair value. Dashed = 300-day average. As of Jul 23, 2026.
Analysis
Healthconn Corp (6665) currently trades at 18.70 TWD, while our model-based Fair Value estimate is 4.88 TWD, implying the stock looks roughly 73.9% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Healthconn Corp generated revenue of 1.1B TWD at a net margin of 0.7%. Revenue declined 11.1% year over year. It earns a return on equity of 0.9%. The balance sheet holds a net cash position of 285M TWD. Fundamentals as of Jul 23, 2026
Our scenario range runs from 3.05 TWD (bear case) to 6.62 TWD (bull case); at 18.70 TWD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 28% below its 52-week high and 2% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -15% fair-value upside, at -74%, 6665 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (15.73 TWD) versus Earnings-Based (1.71 TWD). Highest evidence: Residual Income (76).
Notify me when 6665 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 34
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Healthconn Corp. engages in the health services management in Taiwan and China. The company engages in the provision of health promotion consulting services, precision medicine health management services; genetic testing; and sales of molecular biology, genetics, microbial life science testing, precision instruments, and reagents.
Full company description
Healthconn Corp. engages in the health services management in Taiwan and China. The company engages in the provision of health promotion consulting services, precision medicine health management services; genetic testing; and sales of molecular biology, genetics, microbial life science testing, precision instruments, and reagents. It also offers diagnostic solutions, including microbiology, total lab automation, molecular biology, life sciences, laboratory information systems, and environment and safety solutions; and warehouse and logistics solutions. Healthconn Corp. was founded in 2009 and is based in Taipei, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Healthconn Corp reported revenue of 1.1B TWD in FY2025 versus 1.4B TWD in FY2021, a compound −4.6%/yr. Reported net income was 8.4M TWD in FY2025, compounding −31.2%/yr from FY2021.
6665 screens 74% overvalued. Compare with UnitedHealth Group →
Peer Group
Healthcare Plans · 15 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Healthcare Plans median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Jul 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| UnitedHealth Group UNH | $423.38 | $292.06 | -31% |
| CVS Health Corporation CVS | $104.15 | $42.54 | -59% |
| Elevance Health, Inc ELV | $372.85 | $431.40 | +16% |
| The Cigna Group CI | $304.50 | $495.42 | +63% |
| Humana Inc HUM | $400.00 | $127.61 | -68% |
| Centene Corporation CNC | $66.61 | $111.96 | +68% |
| Molina Healthcare, Inc MOH | $233.31 | $199.31 | -15% |
| Oscar Health, Inc OSCR | $29.10 | $58.20 | +100% |
| Alignment Healthcare, Inc ALHC | $20.60 | $2.37 | -88% |
| Progyny, Inc PGNY | $31.93 | $16.44 | -49% |
Compare Healthconn Corp with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Healthconn Corp (6665) overvalued or undervalued?
What is the fair value of 6665?
What is the quality score of 6665?
What is the revenue of Healthconn Corp (6665)?
What is the net profit margin of 6665?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Healthconn Corp and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.